Gene · 29881
Papers2,068
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,068
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization study. | Cardiovasc Diabetol | 2026 | 42135799 | PubTator, text mining | PubMed |
| Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. | Nutrients | 2026 | 42123990 | PubTator, text mining | PubMed |
| Statin Use and Neuropathic Pain: Evidence from NHANES and Mendelian Randomization Analyses. | Mol Neurobiol | 2026 | 42081017 | PubTator, text mining | PubMed |
Integrated computational and structural understanding of Prunus bokharensis-derived β-Glucan: HRMS, network pharmacology, docking, and MD simulations to discover multi-target interactions for immunomodulation, antimelanoma lipid-hormone axis modulation, and erythroprotection. | Comput Biol Med | 2026 | 42054915 | PubTator, text mining | PubMed |
| Ergosterol as a natural modulator of intestinal cholesterol absorption via NPC1L1: an in silico insight into hypercholesterolemia. | Front Bioinform | 2026 | 42038402 | PubTator, text mining | PubMed |
| Polyphenols as novel NPC1L1 inhibitors: A computational study of natural cholesterol uptake blockers. | J Mol Graph Model | 2026 | 42008961 | PubTator, text mining | PubMed |
| Metabolic Disorders and Inflammatory Bowel Diseases: Unraveling Shared Pathways and Clinical Interactions. | Metabolites | 2026 | 41893332 | PubTator, text mining | PubMed |
| Mechanistic Insights into Lactobacillus harbinensis and Other Probiotics Regulating Lipid Metabolism in T2DM Mice via the PPARγ-LXRα-NPC1L1 Signaling Pathway Based on Multi-Omics Analysis. | Metabolites | 2026 | 41893308 | PubTator, text mining | PubMed |
| Estrogen, Epigenetics, and Cardiometabolic Health: Mechanisms and Therapeutic Strategies in Postmenopausal Women. | Cells | 2026 | 41892319 | PubTator, text mining | PubMed |
| Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41861198 | PubTator, text mining | PubMed |
| PCSK9 Inhibitors and Bipolar Disorder: A Drug Target Mendelian Randomization Study. | Clin Neuropharmacol | 2026 | 41855073 | PubTator, text mining | PubMed |
| Gut microbiota metabolic reprogramming drives the development of metabolic diseases in the host. | Gut Microbes | 2026 | 41830551 | PubTator, text mining | PubMed |
| Virtual Screening of FDA-Approved Compounds: Exploring New Alternatives for HIV Treatment. | ACS Omega | 2026 | 41799137 | PubTator, text mining | PubMed |
| The Lipoprotein(a) Implementation Gap: Bridging Evidence and Clinical Practice. | Rev Cardiovasc Med | 2026 | 41789317 | PubTator, text mining | PubMed |
| Computational Prediction of Deleterious SNPs in the GALNS Gene Implicated in Morquio A Syndrome (MPS IVA). | ACS Omega | 2026 | 41768756 | PubTator, text mining | PubMed |
| A real-world pharmacovigilance study of bempedoic acid plus ezetimibe fixed-dose combination based on the FDA FAERS database. | Medicine (Baltimore) | 2026 | 41760008 | PubTator, text mining | PubMed |
Marine Microalga Tisochrysis lutea F&M-M36 Modulates Gut Microbiota and Intestinal Cholesterol Transport Gene Expression in Association with Selected Early-Stage Metabolic Alterations Under High-Fat Feeding. | Mar Drugs | 2026 | 41745489 | PubTator, text mining | PubMed |
| Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events. | Ann Med | 2026 | 41732846 | PubTator, text mining | PubMed |
| Longdan Xiegan formula as adjuvant therapy for hypertension: A systematic review and meta-analysis. | Medicine (Baltimore) | 2026 | 41731837 | PubTator, text mining | PubMed |
| Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis. | Front Cardiovasc Med | 2026 | 41725935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29881/papers?page=2